• eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept

    Wednesday June 17th 2020

  • Fund+ appoints Luc Debruyne and Gérard Lamarche to the Board of Directors

    Tuesday June 16th 2020

  • Mithra signs LSA for commercialization of Tibelia® in Liechtenstein and Switzerland

    Thursday June 11th 2020

  • Johnson & Johnson announces acceleration of its COVID-19 vaccine candidate

    Thursday June 11th 2020

  • Bioqube Ventures launches Bioqube Factory Fund I

    Wednesday June 10th 2020

  • Biotalys expands executive team and establishes U.S. headquarters to strengthen North American presence

    Wednesday June 10th 2020

  • Nieuwe antivirale benadering voor influenza en Zika

    Wednesday June 10th 2020

  • New analyses of Phase 2 Equator Clinical Program support durable efficacy of Filgotinib in Psoriatic Arthritis

    Monday June 8th 2020

  • Your news here?

  • Gentse en Leuvense onderzoekers steken turbo in ontwikkeling van nieuw soort antibiotica

    Friday June 5th 2020

  • Belgische start-up BioStrand haalt 2 miljoen euro op

    Thursday June 4th 2020

  • Filgotinib demonstrates durable efficacy and consistent safety profile at 52 weeks in Finch 1 and 3 studies in rheumatoid arthritis

    Thursday June 4th 2020

Strategic Partners